Dr Damien Kee
Honorary (Fellow)
Department of Medical Biology (WEHI)
111 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Translating ctDNA into cutaneous melanoma care: An international expert survey
DOI: 10.1016/j.ejca.2026.1166762026
Journal article
Nivolumab and Ipilimumab in Advanced Mismatch Repair–Deficient/Microsatellite Instability–High Noncolorectal Cancers: A Nonrandomized Clinical Trial
DOI: 10.1001/jamaoncol.2025.47212026
Journal article
Systemic Surveillance Guidelines for Uveal Melanoma: A Systematic Review
DOI: 10.1111/ceo.700022026
Journal article
Genomic Therapy Matching in Rare and Refractory Cancers
DOI: 10.1001/jamaoncol.2026.01272025
Journal article
768P Operational challenges of molecular tumour board (MTBs) in the Australasian public healthcare services: A scoping survey to inform the future of precision oncology
DOI: 10.1016/j.annonc.2025.10.11832025
Journal article
797P Real-world experience of liquid biopsy (LBx) vs tissue-based comprehensive genomic profiling (tCGP)
DOI: 10.1016/j.annonc.2025.10.12112023
Research grants (ARC, NHMRC, MRFF)
Using Real World Data to Drive Cancer Care Research and Delivery
RECENT SCHOLARLY WORKS
2025
Journal article
Uncertainty and hope in people with metastatic uveal melanoma in the era of immunotherapy and targeted treatments: a theory-based qualitative study
DOI: 10.1186/s12885-025-14368-62025
Journal article
777P HIF2α pathway aberrations across tumour types: A rare but actionable entity with high germline conversion
DOI: 10.1016/j.annonc.2025.10.11922025
Journal article
1645P A phase Ib study to evaluate the safety, tolerability and efficacy of the combination of encorafenib, binimetinib and palbociclib in patients with BRAF-mutant metastatic melanoma (CELEBRATE)
DOI: 10.1016/j.annonc.2025.08.22732025
Journal article
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial
DOI: 10.1001/jamaoncol.2025.1916